
    
      In brief, a single patient has been identified as having a cystic tumor by diagnostic imaging
      and clinical expertise and based on standards of excellence in clinical care will be offered
      participation in the study for the intracystic implantation of 90yttrium colloid. This
      patient will be followed closely for 4 weeks following 90yttrium colloid treatment and then
      receive standard of care (http://neurosurgery.medicine.dal.ca).
    
  